Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000253588 | SCV000303031 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002518568 | SCV003325985 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-07-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020999 | SCV005033036 | likely benign | Cardiovascular phenotype | 2023-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |